论文部分内容阅读
目的:客观评价我院降糖药使用情况,以提高我院合理用药水平。方法:对我院2008年至2010年降糖药的用药金额、用药频度、日均费用等进行统计分析。结果:3年来我院降糖药用药金额持续增长且幅度较大,降糖药物构成比基本稳定;口服降糖药物日均费用排在前3位的是格列齐特片、阿卡波糖片(进口)、格列吡嗪片,其中日均费用相对较低的是格列齐特片。胰岛素类用药金额排列前3位的是诺和灵30R、来得时及胰岛素注射液。结论:我院降糖药的用药金额呈上升趋势,降糖药的使用基本合理。
Objective: To objectively evaluate the use of hypoglycemic agents in our hospital so as to improve the rational use of drugs in our hospital. Methods: From 2008 to 2010 in our hospital hypoglycemic agents the amount of medication frequency of daily average costs for statistical analysis. Results: In the past three years, the amount of hypoglycemic drug in our hospital continued to increase and the magnitude was large, and the composition ratio of hypoglycemic drugs was basically stable. The top three of the daily average cost of oral hypoglycemic drugs were gliclazide, acarbose Tablets (imported), glipizide tablets, of which the average daily cost is relatively low is gliclazide tablets. Top three insulin dosage medication is Novolin and 30R, when and insulin injection. Conclusion: The dosage of hypoglycemic agents in our hospital is on the rise, and the use of hypoglycemic agents is basically reasonable.